PharmaNet offers a complete range of biostatistical services, including:
 Protocol development, including sample size and power calculations |
| Randomization schedules |
| Statistical analysis plans |
| Statistical programming in SAS® |
| Statistical analyses using current methodologies |
| Interpretation and reporting of data for clinical trial reports and publications |
| Regulatory representation |
| Interim analysis and DMC support |
| Database integration (ISS/ISE preparation) |
The PharmaNet Biostatistics team is distinguished by a large library of published papers. Please click here to see a partial listing.
Mary F. Johnson, PhD Executive Vice President, Biostatistics Dr. Johnson has served as a statistical consultant to the pharmaceutical industry for more than 18 years, advising clients on both statistical and regulatory aspects of clinical development programs. She previously spent 8 years at the FDA as a group leader and statistical reviewer in the Division of Biometrics. As PharmaNet’s Executive Vice President, Biostatistics, Dr. Johnson has managed statistical analysis and programming activities for clinical trials in numerous successful NDA/PLA submissions. |
504 Carnegie Center, Princeton, NJ 08540